J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 75,939 shares at $34.57 ($2.6M) on 2022-04-21, disclosed to the SEC on 2022-04-25.
Open-market sale of $2.6M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.57 | 22,715 | $785K | 29.7% |
| 2 | $34.57 | 22,715 | $785K | 29.7% |
| 3 | $35.73 | 4,062 | $145K | 5.5% |
| 4 | $35.73 | 4,062 | $145K | 5.5% |
| 5 | $36.70 | 2,220 | $81K | 3.1% |
| 6 | $37.90 | 1,003 |
| $38K |
| 1.4% |
| 7 | $34.54 | 9,162 | $316K | 12.0% |
| 8 | $34.54 | 9,162 | $316K | 12.0% |
| 9 | $35.15 | 838 | $29K | 1.1% |
| Total | $34.80 avg | 75,939 | $2.6M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |
| FATE | SELL | 2022-01-13 | $1.4M | — | Filing → |